ZEVASKYN is expected to be available beginning in the third quarter of 2025 through ZEVASKYN Qualified Treatment Centers, located across the U.S. with experience in cell and gene therapy.
Amazon clarified that although it considered displaying import charges on items sold through its site for ultra-discount items, the plan “was never approved and not going to happen.”
Argus said rising avocado, chicken, and pepper prices, growing competition among restaurants, and higher wage and store location costs were headwinds for the taco and burrito chain.
Domino's has been selling on Uber Eats, but the exclusivity of that partnership will end in May. Domino's has indicated it will work with multiple food delivery players.
HG Vora, which holds a less than 5% stake in Penn, said the company's action was "self-serving" and that it would continue pushing for board representation.
HSBC noted that while the market has assumed a significant market share for Eli Lilly, these expectations may be revised in light of potential economic sensitivity to the adoption curve for weight loss drugs.
In a turbulent year for financial markets, US equities and real estate investment trusts are still bearing the brunt of the selling so far in 2025, based on a set of ETFs.
The $150 billion investment will include more than $30 billion in research and development to advance and continue IBM's American manufacturing of mainframe and quantum computers.
For the full year, Revvity raised its revenue guidance to a range of $2.83 billion to $2.87 billion to reflect recent changes in foreign currency exchange rates.
Bernstein stated that after high Federal Aviation Administration (FAA) scrutiny, Boeing Commercial Airplanes "should be on a much firmer path than in 2023.”
